<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03598491</url>
  </required_header>
  <id_info>
    <org_study_id>chhwang10</org_study_id>
    <nct_id>NCT03598491</nct_id>
  </id_info>
  <brief_title>Feasibility of a Water-soluble Contrast Application Into Dysphagia Evaluation</brief_title>
  <official_title>Feasibility of a Water-soluble Contrast Application Into Dysphagia Evaluation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ulsan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ulsan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      In traditional video-fluoroscopic-swallowing study, a lipid-soluble contrast (barium sulfate)
      has been used more than 30 years. However, it can cause chemical pneumonitis and subsequently
      impair reliability of video-fluoroscopic-swallowing study if aspirated. The authors reviewed
      the safety and usefulness of an water soluble agent-based swallowing test.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parallel-group, case-controlled trial was conducted from September 2015 to November 2017. All
      the patients who referred for video-fluoroscopic-swallowing study were screened.

      Based on the pre-emptive evaluation, high-risky patients were allocated to iohexol
      (Omnipaque)-used video-fluoroscopic-swallowing study and others were allocated to barium
      sulfate-used video-fluoroscopic-swallowing study.

      Statistical Package for the Social Sciences 24 was used to perform statistical analysis for
      the data. Quantitative data were presented as mean Â± standard errors.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 18, 2015</start_date>
  <completion_date type="Actual">December 31, 2017</completion_date>
  <primary_completion_date type="Actual">November 17, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Laryngeal protection</measure>
    <time_frame>within 1 hour after video-fluoroscopic-swallowing study</time_frame>
    <description>Penetration aspiration scale (zero to eight)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Oral feeding</measure>
    <time_frame>within 1 week before video-fluoroscopic-swallowing study</time_frame>
    <description>Success of Oral feeding after video-fluoroscopic-swallowing study or not</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Tracheostomy</measure>
    <time_frame>within 1 day before video-fluoroscopic-swallowing study</time_frame>
    <description>Presence of tracheostomy or not</description>
  </other_outcome>
  <other_outcome>
    <measure>Allergic reaction</measure>
    <time_frame>within 2 days before video-fluoroscopic-swallowing study</time_frame>
    <description>Contrast allergic reaction to the Iohexl</description>
  </other_outcome>
  <other_outcome>
    <measure>Symptoms of chemical pneumonitis</measure>
    <time_frame>within 1 week before video-fluoroscopic-swallowing study</time_frame>
    <description>Radiological alteration on a chest xray</description>
  </other_outcome>
  <other_outcome>
    <measure>Hospital stay</measure>
    <time_frame>within 1 day after discharge</time_frame>
    <description>Total days from admission to discharge</description>
  </other_outcome>
  <other_outcome>
    <measure>Days to discharge</measure>
    <time_frame>within 1 day after discharge</time_frame>
    <description>Total Days from video-fluoroscopic-swallowing study to discharge</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">755</enrollment>
  <condition>Dysphagia</condition>
  <condition>Swallowing Disorder</condition>
  <arm_group>
    <arm_group_label>Iohexol</arm_group_label>
    <description>Iohexol was applied in video-fluoroscopic-swallowing study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Barium</arm_group_label>
    <description>Barium was applied in video-fluoroscopic-swallowing study</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All the inpatients and outpatients who referred for video-fluoroscopic-swallowing study
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All the patients who referred for video-fluoroscopic-swallowing study

        Exclusion Criteria:

          -  none
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chang Ho Hwang, M.D., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Ulsan University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Ulsan University Hospital</name>
      <address>
        <city>Ulsan</city>
        <zip>682-714</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>September 2019</verification_date>
  <study_first_submitted>July 13, 2018</study_first_submitted>
  <study_first_submitted_qc>July 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2018</study_first_posted>
  <last_update_submitted>September 26, 2019</last_update_submitted>
  <last_update_submitted_qc>September 26, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">September 27, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ulsan University Hospital</investigator_affiliation>
    <investigator_full_name>Chang Ho Hwang</investigator_full_name>
    <investigator_title>Associated Professor, PhD and MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Deglutition Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

